COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefits and Risks.

ABSTRACT:

Purpose of review

COVID-19 pandemic has been the major threat to the global public health for a year (last of 2019-till date); and unfortunately, there is still as no specific antiviral agent which can be effectively used against this disease curation. Present review focused on the application of the convalescent plasma (CP) therapy as a quick remediation of the disease severity.

Recent findings

While several drugs have been repurposed based on a number of completed clinical trials together with a huge ongoing effort to develop appropriate vaccine against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the therapeutic approach of the CP therapy appears to be one of the effective methods to rescue the severely affected COVID-19 patients. Such a therapy based

SUBMITTER: Noor R 

PROVIDER: S-EPMC8254626 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature